Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Two Mechanical Methods of Outpatient Ripening of the Cervix

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women between 39 and 41 weeks gestational age who desire elective induction of labor, based on reliable estimated gestational age (defined as ultrasonography performed before 14 weeks 0 days, or a certain last menstrual period consistent with ultrasonography performed before 21 weeks 0 days).~Exclusion Criteria:~* 1. Risk factors for placental insufficiency or intra-partum complication such as intra-uterine growth restriction, hypertensive disease, diabetes requiring insulin therapy, multiple gestation, history of previous hysterotomy, cholestasis of pregnancy, placental abnormalities including low lying placenta (\< 2 cm from cervical os), maternal cardiac disease, maternal pulmonary disease, known fetal anomaly, fetal demise, etc.~* 2. Simplified Bishop score must be \<6 and cervical dilation \<2 cm.~* 3. Women must be able to give informed consent.~* 4. Concern regarding fetal well-being, conditions which preclude vaginal birth, group B strep carriers, patients who are HIV, Hep B or Hep C positive.~* 5. Women allergic to povidone-iodine, aquacryl hydrogel or the latex-free Foley catheter.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Trans-cervical cervical balloon (Type: EXPERIMENTAL): 17 F non-latex Foley catheter will be placed and balloon filled with 30 cc of sterile normal saline.
- Hygroscopic cervical dilators (Type: EXPERIMENTAL): Dilapan-S hygroscopic dilators will be placed into the cervix at the level of the internal os.

Based on this trial design, predict the completion outcome and termination type (if applicable).